A Mixed-Methods Study on Patient Perceptions of Traditional Chinese Medicine in Lifestyle-Based Chronic Disease Management
Global Health Care · 2025
DOI: 10.63808/ghc.v1i2.174 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift Global Health Care, 2025. Verfasst von Yin Chao. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Traditional Chinese Medicine (TCM) has become an alternative approach to chronic disease control through lifestyle-based treatment that emphasizes comprehensive treatment. Based on a mixed-methods research design incorporating qualitative interviews and quantitative survey data, the study investigated patient perceptions regarding the incorporation of TCM into lifestyle modification programs. A total of 156 patients with diabetes, hypertension, and cardiovascular disease were recruited from three healthcare centers. Semi-structured interviews were conducted with 24 participants, and validated questionnaires were distributed to all the participants. Results indicated very positive attitudes with 78.2% reporting enhanced quality of life and 84.6% satisfaction with TCM-enhanced interventions. Thematic analysis revealed four themes: cultural congruence, perceived efficacy, enhanced communication, and improved compliance. Quantitative analysis revealed strong correlations between TCM acceptance and cultural background (r=0.67, p
Zitieren
APA
Chao, Y. (2025). A Mixed-Methods Study on Patient Perceptions of Traditional Chinese Medicine in Lifestyle-Based Chronic Disease Management. Global Health Care. https://doi.org/10.63808/ghc.v1i2.174
Vancouver
Chao Y. A Mixed-Methods Study on Patient Perceptions of Traditional Chinese Medicine in Lifestyle-Based Chronic Disease Management. Global Health Care. 2025. doi:10.63808/ghc.v1i2.174
BibTeX
@article{Chao2025,
author = {Chao, Yin},
title = {A Mixed-Methods Study on Patient Perceptions of Traditional Chinese Medicine in Lifestyle-Based Chronic Disease Management},
journal = {Global Health Care},
year = {2025},
doi = {10.63808/ghc.v1i2.174}
}
EUVIMED